Literature DB >> 921451

Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma.

A N Reddy, S J Grosberg, S Wapnick.   

Abstract

Hepatomegaly and abnormal liver function can occur in nonmetastatic malignancies. A patient with metastatic prostatic adenocarcinoma that had spared the liver and extrahepatic biliary tree is described. He had puzzling episodes of jaundice for a period of 2 1/2 years. The results of appropriate investigations and an exploratory laparotomy performed dlring the patient's four antemortem hospitalizations were indicative of "recurrent intrahepatic cholestasis," the cause of which remained an enigma even after exploratory laparotomy. At autopsy, no evidence of hepatic metastases or extrahepatic biliary obstruction was found. Alcohol, hepatotoxic drugs, toxins, viral and chronic active hepatitis, hemolysis, and extrahepatic biliary obstruction were eliminated as causes of the jaundice. We believe that the intermittent intrahepatic cholestasis is one of the nonmetastatic manifestations (nonmetastatic hepatopathy of malignancy) of the prostatic adenocarcinoma.

Entities:  

Mesh:

Year:  1977        PMID: 921451

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Authors:  Akihiro Okano; Masaya Ohana; Fusako Kusumi
Journal:  Clin J Gastroenterol       Date:  2014-04-12

2.  Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.

Authors:  Min Kyu Kang; Jung Gil Park; Heon Ju Lee
Journal:  Med Princ Pract       Date:  2018-01-10       Impact factor: 1.927

3.  Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature.

Authors:  Pınar Gökçen; Kaan Gökçen; Erol Çakmak; Gökhan Gökçe
Journal:  Turk J Urol       Date:  2018-09-12

4.  Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.

Authors:  David Kato; Chinemerem Okwara; Christopher Moreland; Allan Parker
Journal:  J Investig Med High Impact Case Rep       Date:  2014-06-24

5.  Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.

Authors:  Tomomi Kuramoto; Hiroya Senzaki; Hiroyuki Koike; Kenji Yamagiwa; Shinobu Tamura; Tokuzou Fujimoto; Takeshi Inagaki
Journal:  Case Rep Urol       Date:  2013-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.